Welcome to our year-end edition of M&A Insights, where we preview some of the themes we expect to shape deal-making over the next 12 months.
Continued volatility in the debt markets has resulted in another subdued year for...more
12/13/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Management ,
Capital Markets ,
EU ,
Financial Sponsors ,
Global Dealmaking ,
Global Market ,
Investment ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Publicly-Traded Companies ,
Software Developers ,
Technology
A summary of changes to Schedule 13D/G reporting. On October 11, 2023, the U.S. Securities and Exchange Commission (the SEC) adopted its final rule (the Final Rule) amending certain beneficial ownership reporting...more
The election of Joe Biden is likely to usher in an era of more stable and predictable politics in the U.S., increasing the kind of investor confidence on which M&A transactions thrive....more